Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis

Journal of Leukocyte Biology

Volumn 99, Issue 6, 2016, Pages 1153-1164

  Whibley, Natasha ^a   Tritto, Elaine ^b   Traggiai, Elisabetta ^b   Kolbinger, Frank ^b   Moulin, Pierre ^b   Brees, Dominique ^b   Coleman, Bianca M ^a   Mamo, Anna J ^a   Garg, Abhishek V ^a   Jaycox, Jillian R ^a   Siebenlist, Ulrich ^c   Kammüller, Michael ^b   Gaffen, Sarah L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Anticytokine therapy; Fungal; IL 17R; Psoriasis; Th17

Indexed keywords

CYTOKINE ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17AF; INTERLEUKIN 17F; UNCLASSIFIED DRUG; BLOCKING ANTIBODY; FUNGUS ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGUS IMMUNITY; GENETIC ASSOCIATION; INFECTION SENSITIVITY; KNOCKOUT MOUSE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; OROPHARYNX CANDIDIASIS; PRIORITY JOURNAL; ACUTE DISEASE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CANDIDA; DISEASE PREDISPOSITION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUTH MUCOSA; MUCOSAL IMMUNITY; PATHOLOGY; THRUSH;

ACUTE DISEASE; ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, FUNGAL; ANTIBODIES, NEUTRALIZING; CANDIDA; CANDIDIASIS, ORAL; DISEASE SUSCEPTIBILITY; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, MUCOSAL; INTERLEUKIN-17; MICE, INBRED C57BL; MOUTH MUCOSA;

EID: 84971468113     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.4A0915-428R     Document Type: Article

References (74)

1. Patel, D. D., Lee, D. M., Kolbinger, F., Antoni, C. (2013) Effect of IL-17A blockade with secukinumab in autoimmune diseases. Ann. Rheum. Dis. 72 (Suppl 2), 2116-2123.
2. Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., Banerjee, S. (2012) Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N. Engl. J. Med. 366, 1190-1199.
3. Papp, K. A., Leonardi, C., Menter, A., Ortonne, J. P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H., Baumgartner, S. (2012) Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N. Engl. J. Med. 366, 1181-1189.
4. ERASURE Study Group; FIXTURE Study Group. (2014) Secukinumab in plaque psoriasis—results of two phase 3 trials. N. Engl. J. Med. 371, 326-338.
5. Sanford, M., McKeage, K. (2015) Secukinumab: first global approval. Drugs 75, 329-338.
6. Huppler, A. R., Bishu, S., Gaffen, S. L. (2012) Mucocutaneous candidiasis: the IL-17 pathway and implications for targeted immunotherapy. Arthritis Res. Ther. 14, 217.
7. Fidel, P. L., Jr. (2011) Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis. Adv. Dent. Res. 23, 45-49.
8. Glocker, E., Grimbacher, B. (2010) Chronic mucocutaneous candidiasis and congenital susceptibility to Candida. Curr. Opin. Allergy Clin. Immunol. 10, 542-550.
9. Milner, J. D., Holland, S. M. (2013) The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases. Nat. Rev. Immunol. 13, 635-648.
10. Boisson, B., Wang, C., Pedergnana, V., Wu, L., Cypowyj, S., Rybojad, M., Belkadi, A., Picard, C., Abel, L., Fieschi, C., Puel, A., Li, X., Casanova, J.-L. (2013) An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity 39, 676-686.
11. Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., Gumbleton, M., Toulon, A., Bodemer, C., El-Baghdadi, J., Whitters, M., Paradis, T., Brooks, J., Collins, M., Wolfman, N. M., Al-Muhsen, S., Galicchio, M., Abel, L., Picard, C., Casanova, J.-L. (2011) Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332, 65-68.
12. Ling, Y., Cypowyj, S., Aytekin, C., Galicchio, M., Camcioglu, Y., Nepesov, S., Ikinciogullari, A., Dogu, F., Belkadi, A., Levy, R., Migaud, M., Boisson, B., Bolze, A., Itan, Y., Goudin, N., Cottineau, J., Picard, C., Abel, L., Bustamante, J., Casanova, J. L., Puel, A. (2015) Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis. J. Exp. Med. 212, 619-631.
13. Okada, S., Markle, J. G., Deenick, E. K., Mele, F., Averbuch, D., Lagos, M., Alzahrani, M., Al-Muhsen, S., Halwani, R., Ma, C. S., Wong, N., Soudais, C., Henderson, L. A., Marzouqa, H., Shamma, J., Gonzalez, M., Martinez-Barricarte, R., Okada, C., Avery, D. T., Latorre, D., Deswarte, C., Jabot-Hanin, F., Torrado, E., Fountain, J., Belkadi, A., Itan, Y., Boisson, B., Migaud, M., Arlehamn, C. S., Sette, A., Breton, S., McCluskey, J., Rossjohn, J., de Villartay, J. P., Moshous, D., Hambleton, S., Latour, S., Arkwright, P. D., Picard, C., Lantz, O., Engelhard, D., Kobayashi, M., Abel, L., Cooper, A. M., Notarangelo, L. D., Boisson-Dupuis, S., Puel, A., Sallusto, F., Bustamante, J., Tangye, S. G., Casanova, J. L. (2015) Immunodeficienes. Impairment of immunity to Candida and Mycobacterium in humans with biallelic RORC mutations. Science 349, 606-613.
14. Puel, A., D öffinger, R., Natividad, A., Chrabieh, M., Barcenas-Morales, G., Picard, C., Cobat, A., Ouachée-Chardin, M., Toulon, A., Bustamante, J., Al-Muhsen, S., Al-Owain, M., Arkwright, P. D., Costigan, C., McConnell, V., Cant, A. J., Abinun, M., Polak, M., Bougnères, P. F., Kumararatne, D., Marodi, L., Nahum, A., Roifman, C., Blanche, S., Fischer, A., Bodemer, C., Abel, L., Lilic, D., Casanova, J. L. (2010) Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med. 207, 291-297.
15. Kisand, K., Bøe Wolff, A. S., Podkrajsek, K. T., Tserel, L., Link, M., Kisand, K. V., Ersvaer, E., Perheentupa, J., Erichsen, M. M., Bratanic, N., Meloni, A., Cetani, F., Perniola, R., Ergun-Longmire, B., Maclaren, N., Krohn, K. J., Pura, M., Schalke, B., Ströbel, P., Leite, M. I., Battelino, T., Husebye, E. S., Peterson, P., Willcox, N., Meager, A. (2010) Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J. Exp. Med. 207, 299-308.
16. Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., Davis, J., Hsu, A., Asher, A. I., O’Shea, J., Holland, S. M., Paul, W. E., Douek, D. C. (2008) Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452, 773-776.
17. Minegishi, Y., Karasuyama, H. (2008) Genetic origins of hyper-IgE syndrome. Curr. Allergy Asthma Rep. 8, 386-391.
18. Renner, E. D., Rylaarsdam, S., Anover-Sombke, S., Rack, A. L., Reichenbach, J., Carey, J. C., Zhu, Q., Jansson, A. F., Barboza, J., Schimke, L. F., Leppert, M. F., Getz, M. M., Seger, R. A., Hill, H. R., Belohradsky, B. H., Torgerson, T. R., Ochs, H. D. (2008) Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome. J. Allergy Clin. Immunol. 122, 181-187.
19. Wjst, M., Lichtner, P., Meitinger, T., Grimbacher, B. (2009) STAT3 single-nucleotide polymorphisms and STAT3 mutations associated with hyper-IgE syndrome are not responsible for increased serum IgE serum levels in asthma families. Eur. J. Hum. Genet. 17, 352-356.
20. Minegishi, Y., Karasuyama, H. (2009) Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int. Immunol. 21, 105-112.
21. Farah, C. S., Hu, Y., Riminton, S., Ashman, R. B. (2006) Distinct roles for interleukin-12p40 and tumour necrosis factor in resistance to oral candidiasis defined by gene-targeting. Oral Microbiol. Immunol. 21, 252-255.
22. Conti, H. R., Peterson, A. C., Brane, L., Huppler, A. R., Hernández-Santos, N., Whibley, N., Garg, A. V., Simpson-Abelson, M. R., Gibson, G. A., Mamo, A. J., Osborne, L. C., Bishu, S., Ghilardi, N., Siebenlist, U., Watkins, S. C., Artis, D., McGeachy, M. J., Gaffen, S. L. (2014) Oral-resident natural Th17 cells and gd T cells control opportunistic Candida albicans infections. J. Exp. Med. 211, 2075-2084.
23. Conti, H. R., Shen, F., Nayyar, N., Stocum, E., Sun, J. N., Lindemann, M. J., Ho, A. W., Hai, J. H., Yu, J. J., Jung, J. W., Filler, S. G., Masso-Welch, P., Edgerton, M., Gaffen, S. L. (2009) Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J. Exp. Med. 206, 299-311.
24. Ho, A. W., Shen, F., Conti, H. R., Patel, N., Childs, E. E., Peterson, A. C., Hernández-Santos, N., Kolls, J. K., Kane, L. P., Ouyang, W., Gaffen, S. L. (2010) IL-17RC is required for immune signaling via an extended SEF/ IL-17R signaling domain in the cytoplasmic tail. J. Immunol. 185, 1063-1070.
25. Kagami, S., Rizzo, H. L., Kurtz, S. E., Miller, L. S., Blauvelt, A. (2010) IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J. Immunol. 185, 5453-5462.
26. Netea, M. G., Mar ódi, L. (2010) Innate immune mechanisms for recognition and uptake of Candida species. Trends Immunol. 31, 346-353.
27. Huang, W., Na, L., Fidel, P. L., Schwarzenberger, P. (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190, 624-631.
28. Gaffen, S. L., Jain, R., Garg, A., Cua, D. (2014) The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585-600.
29. Iwakura, Y., Ishigame, H., Saijo, S., Nakae, S. (2011) Functional specialization of interleukin-17 family members. Immunity 34, 149-162.
30. Chang, S. H., Dong, C. (2007) A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res. 17, 435-440.
31. Ely, L. K., Fischer, S., Garcia, K. C. (2009) Structural basis of receptor sharing by interleukin 17 cytokines. Nat. Immunol. 10, 1245-1251.
32. Liang, S. C., Long, A. J., Bennett, F., Whitters, M. J., Karim, R., Collins, M., Goldman, S. J., Dunussi-Joannopoulos, K., Williams, C. M., Wright, J. F., Fouser, L. A. (2007) An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J. Immunol. 179, 7791-7799.
33. Wright, J. F., Bennett, F., Li, B., Brooks, J., Luxenberg, D. P., Whitters, M. J., Tomkinson, K. N., Fitz, L. J., Wolfman, N. M., Collins, M., Dunussi-Joannopoulos, K., Chatterjee-Kishore, M., Carreno, B. M. (2008) The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J. Immunol. 181, 2799-2805.
34. Wright, J. F., Guo, Y., Quazi, A., Luxenberg, D. P., Bennett, F., Ross, J. F., Qiu, Y., Whitters, M. J., Tomkinson, K. N., Dunussi-Joannopoulos, K., Carreno, B. M., Collins, M., Wolfman, N. M. (2007) Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells. J. Biol. Chem. 282, 13447-13455.
35. Fouser, L. A., Wright, J. F., Dunussi-Joannopoulos, K., Collins, M. (2008) Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol. Rev. 226, 87-102.
36. Ozaki, K., Leonard, W. J. (2002) Cytokine and cytokine receptor pleiotropy and redundancy. J. Biol. Chem. 277, 29355-29358.
37. Onishi, R., Gaffen, S. L. (2010) Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129, 311-321.
38. Li, H., Chen, J., Huang, A., Stinson, J., Heldens, S., Foster, J., Dowd, P., Gurney, A. L., Wood, W. I. (2000) Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc. Natl. Acad. Sci. USA 97, 773-778.
39. Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., Muchamuel, T., Hurst, S. D., Zurawski, G., Leach, M. W., Gorman, D. M., Rennick, D. M. (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985-995.
40. Angkasekwinai, P., Park, H., Wang, Y. H., Wang, Y. H., Chang, S. H., Corry, D. B., Liu, Y. J., Zhu, Z., Dong, C. (2007) Interleukin 25 promotes the initiation of proallergic type 2 responses. J. Exp. Med. 204, 1509-1517.
41. Lee, J., Ho, W. H., Maruoka, M., Corpuz, R. T., Baldwin, D. T., Foster, J. S., Goddard, A. D., Yansura, D. G., Vandlen, R. L., Wood, W. I., Gurney, A. L. (2001) IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276, 1660-1664.
42. Yamaguchi, Y., Fujio, K., Shoda, H., Okamoto, A., Tsuno, N. H., Takahashi, K., Yamamoto, K. (2007) IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis. J. Immunol. 179, 7128-7136.
43. Starnes, T., Broxmeyer, H. E., Robertson, M. J., Hromas, R. (2002) Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol. 169, 642-646.
44. Ishigame, H., Kakuta, S., Nagai, T., Kadoki, M., Nambu, A., Komiyama, Y., Fujikado, N., Tanahashi, Y., Akitsu, A., Kotaki, H., Sudo, K., Nakae, S., Sasakawa, C., Iwakura, Y. (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30, 108-119.
45. Claudio, E., Sønder, S. U., Saret, S., Carvalho, G., Ramalingam, T. R., Wynn, T. A., Chariot, A., Garcia-Perganeda, A., Leonardi, A., Paun, A., Chen, A., Ren, N. Y., Wang, H., Siebenlist, U. (2009) The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J. Immunol. 182, 1617-1630.
46. Kamai, Y., Kubota, M., Kamai, Y., Hosokawa, T., Fukuoka, T., Filler, S. (2001) New model of oropharyngeal candidiasis in mice. Antimicrob. Agents Chemother. 45, 3195-3197.
47. Hernández-Santos, N., Huppler, A. R., Peterson, A. C., Khader, S. A., McKenna, K. C., Gaffen, S. L. (2013) Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol. 6, 900-910.
48. Solis, N. V., Filler, S. G. (2012) Mouse model of oropharyngeal candidiasis. Nat. Protoc. 7, 637-642.
49. Conti, H. R., Whibley, N., Coleman, B. M., Garg, A. V., Jaycox, J. R., Gaffen, S. L. (2015) Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis. PLoS One 10, e0122807.
50. Huppler, A. R., Verma, A. H., Conti, H. R., Gaffen, S. L. (2015) Neutrophils do not express IL-17A in the context of acute oropharyngeal candidiasis. Pathogens 4, 559-572.
51. Shen, F., Ruddy, M. J., Plamondon, P., Gaffen, S. L. (2005) Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17-and TNF-alpha-induced genes in bone cells. J. Leukoc. Biol. 77, 388-399.
52. Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., Gaffen, S. L. (2004) Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/ enhancer-binding protein family members. J. Biol. Chem. 279, 2559-2567.
53. Miossec, P. (2003) Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum. 48, 594-601.
54. Ferreira, M. C., Whibley, N., Mamo, A. J., Siebenlist, U., Chan, Y. R., Gaffen, S. L. (2014) Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis. Infect. Immun. 82, 1030-1035.
55. Iliev, I. D., Funari, V. A., Taylor, K. D., Nguyen, Q., Reyes, C. N., Strom, S. P., Brown, J., Becker, C. A., Fleshner, P. R., Dubinsky, M., Rotter, J. I., Wang, H. L., McGovern, D. P., Brown, G. D., Underhill, D. M. (2012) Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336, 1314-1317.
56. Gladiator, A., Wangler, N., Trautwein-Weidner, K., LeibundGut-Landmann, S. (2013) Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J. Immunol. 190, 521-525.
57. Saijo, S., Ikeda, S., Yamabe, K., Kakuta, S., Ishigame, H., Akitsu, A., Fujikado, N., Kusaka, T., Kubo, S., Chung, S. H., Komatsu, R., Miura, N., Adachi, Y., Ohno, N., Shibuya, K., Yamamoto, N., Kawakami, K., Yamasaki, S., Saito, T., Akira, S., Iwakura, Y. (2010) Dectin-2 recognition of a-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32, 681-691.
58. Trautwein-Weidner, K., Gladiator, A., Nur, S., Diethelm, P., LeibundGut-Landmann, S. (2015) IL-17-mediated antifungal defense in the oral mucosa is independent of neutrophils. Mucosal Immunol. 8, 221-231.
59. Miossec, P., Kolls, J. K. (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat. Rev. Drug Discov. 11, 763-776.
60. Freeman, A. F., Holland, S. M. (2008) The hyper-IgE syndromes. Immunol. Allergy Clin. North Am. 28, 277-291, viii (viii.).
61. Haak, S., Croxford, A. L., Kreymborg, K., Heppner, F. L., Pouly, S., Becher, B., Waisman, A. (2009) IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119, 61-69.
62. Luo, Z., Lei, H., Sun, Y., Liu, X., Su, D. F. (2015) Orosomucoid, an acute response protein with multiple modulating activities. J. Physiol. Biochem. 71, 329-340.
63. Nakamura, K., Ito, I., Kobayashi, M., Herndon, D. N., Suzuki, F. (2015) Orosomucoid 1 drives opportunistic infections through the polarization of monocytes to the M2b phenotype. Cytokine 73, 8-15.
64. Joly, S., Eisenbarth, S. C., Olivier, A. K., Williams, A., Kaplan, D. H., Cassel, S. L., Flavell, R. A., Sutterwala, F. S. (2012) Cutting edge: Nlrp10 is essential for protective antifungal adaptive immunity against Candida albicans. J. Immunol. 189, 4713-4717.
65. Rabeony, H., Petit-Paris, I., Garnier, J., Barrault, C., Pedretti, N., Guilloteau, K., Jegou, J. F., Guillet, G., Huguier, V., Lecron, J. C., Bernard, F. X., Morel, F. (2014) Inhibition of keratinocyte differentiation by the synergistic effect of IL-17A, IL-22, IL-1a, TNFa and oncostatin M. PLoS One 9, e101937.
66. Hieshima, K., Ohtani, H., Shibano, M., Izawa, D., Nakayama, T., Kawasaki, Y., Shiba, F., Shiota, M., Katou, F., Saito, T., Yoshie, O. (2003) CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J. Immunol. 170, 1452-1461.
67. Edgerton, M., Koshlukova, S. E., Araujo, M. W., Patel, R. C., Dong, J., Bruenn, J. A. (2000) Salivary histatin 5 and human neutrophil defensin 1 kill Candida albicans via shared pathways. Antimicrob. Agents Chemother. 44, 3310-3316.
68. Nograles, K. E., Zaba, L. C., Guttman-Yassky, E., Fuentes-Duculan, J., Suárez-Fariñas, M., Cardinale, I., Khatcherian, A., Gonzalez, J., Pierson, K. C., White, T. R., Pensabene, C., Coats, I., Novitskaya, I., Lowes, M. A., Krueger, J. G. (2008) Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br. J. Dermatol. 159, 1092-1102.
69. Reich, K., Papp, K. A., Matheson, R. T., Tu, J. H., Bissonnette, R., Bourcier, M., Gratton, D., Kunynetz, R. A., Poulin, Y., Rosoph, L. A., Stingl, G., Bauer, W. M., Salter, J. M., Falk, T. M., Blödorn-Schlicht, N. A., Hueber, W., Sommer, U., Schumacher, M. M., Peters, T., Kriehuber, E., Lee, D. M., Wieczorek, G. A., Kolbinger, F., Bleul, C. C. (2015) Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis. Exp. Dermatol. 24, 529-535.
70. Von Vietinghoff, S., Ley, K. (2009) IL-17A controls IL-17F production and maintains blood neutrophil counts in mice. J. Immunol. 183, 865-873.
71. Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., Napolitani, G. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639-646.
72. Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S., Lanzavecchia, A., Sallusto, F. (2012) Pathogen-induced human TH17 cells produce IFN-g or IL-10 and are regulated by IL-1b. Nature 484, 514-518.
73. Bär, E., Gladiator, A., Bastidas, S., Roschitzki, B., Acha-Orbea, H., Oxenius, A., LeibundGut-Landmann, S. (2012) A novel Th cell epitope of Candida albicans mediates protection from fungal infection. J. Immunol. 188, 5636-5643.
74. Moyes, D. L., Naglik, J. R. (2011) Mucosal immunity and Candida albicans infection. Clin. Dev. Immunol. 2011, 346307.